157 related articles for article (PubMed ID: 38308949)
21. Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.
Karukonda P; Odhiambo D; Mowery YM
Mol Carcinog; 2022 Feb; 61(2):225-238. PubMed ID: 34964992
[TBL] [Abstract][Full Text] [Related]
22. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response.
Mihanfar A; Asghari F; Majidinia M
Mol Biol Rep; 2024 Mar; 51(1):474. PubMed ID: 38553623
[TBL] [Abstract][Full Text] [Related]
23. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.
Edwards TG; Bloom DC; Fisher C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259
[TBL] [Abstract][Full Text] [Related]
24. ATR Inhibition in Advanced Urothelial Carcinoma.
Leibrandt RC; Tu MJ; Yu AM; Lara PN; Parikh M
Clin Genitourin Cancer; 2023 Apr; 21(2):203-207. PubMed ID: 36604210
[TBL] [Abstract][Full Text] [Related]
25. 3F-Box protein 32 degrades ataxia telangiectasia and Rad3-related and regulates DNA damage response induced by gemcitabine in pancreatic cancer.
Yang C; Fan P; Zhu S; Yang H; Jin X; Wu H
Oncol Lett; 2018 Jun; 15(6):8878-8884. PubMed ID: 29805624
[TBL] [Abstract][Full Text] [Related]
26. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases.
Cortez D
J Biol Chem; 2003 Sep; 278(39):37139-45. PubMed ID: 12847089
[TBL] [Abstract][Full Text] [Related]
27. First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Yap TA; Tan DSP; Terbuch A; Caldwell R; Guo C; Goh BC; Heong V; Haris NRM; Bashir S; Drew Y; Hong DS; Meric-Bernstam F; Wilkinson G; Hreiki J; Wengner AM; Bladt F; Schlicker A; Ludwig M; Zhou Y; Liu L; Bordia S; Plummer R; Lagkadinou E; de Bono JS
Cancer Discov; 2021 Jan; 11(1):80-91. PubMed ID: 32988960
[TBL] [Abstract][Full Text] [Related]
28. Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors.
Turchick A; Zimmermann A; Chiu LY; Dahmen H; Elenbaas B; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Ther; 2023 Jul; 22(7):859-872. PubMed ID: 37079339
[TBL] [Abstract][Full Text] [Related]
29. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.
Yajima H; Lee KJ; Zhang S; Kobayashi J; Chen BP
J Mol Biol; 2009 Jan; 385(3):800-10. PubMed ID: 19071136
[TBL] [Abstract][Full Text] [Related]
30. ATM loss disrupts the autophagy-lysosomal pathway.
Cheng A; Tse KH; Chow HM; Gan Y; Song X; Ma F; Qian YXY; She W; Herrup K
Autophagy; 2021 Aug; 17(8):1998-2010. PubMed ID: 32757690
[TBL] [Abstract][Full Text] [Related]
31. Ataxia Telangiectasia and Rad3-Related Activation by DNA Damage Mitigates Maladaptive Repair after Acute Kidney Injury.
Bonventre JV
Nephron; 2022; 146(3):274-277. PubMed ID: 34649246
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
Savva C; De Souza K; Ali R; Rakha EA; Green AR; Madhusudan S
Breast Cancer Res Treat; 2019 May; 175(1):105-115. PubMed ID: 30746633
[TBL] [Abstract][Full Text] [Related]
34. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
35. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells.
Moolmuang B; Ruchirawat M
J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808
[TBL] [Abstract][Full Text] [Related]
36. Thr-1989 phosphorylation is a marker of active ataxia telangiectasia-mutated and Rad3-related (ATR) kinase.
Nam EA; Zhao R; Glick GG; Bansbach CE; Friedman DB; Cortez D
J Biol Chem; 2011 Aug; 286(33):28707-28714. PubMed ID: 21705319
[TBL] [Abstract][Full Text] [Related]
37. Cell stretching activates an ATM mechano-transduction pathway that remodels cytoskeleton and chromatin.
Bastianello G; Porcella G; Beznoussenko GV; Kidiyoor G; Ascione F; Li Q; Cattaneo A; Matafora V; Disanza A; Quarto M; Mironov AA; Oldani A; Barozzi S; Bachi A; Costanzo V; Scita G; Foiani M
Cell Rep; 2023 Dec; 42(12):113555. PubMed ID: 38088930
[TBL] [Abstract][Full Text] [Related]
38. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells.
Kwok M; Davies N; Agathanggelou A; Smith E; Oldreive C; Petermann E; Stewart G; Brown J; Lau A; Pratt G; Parry H; Taylor M; Moss P; Hillmen P; Stankovic T
Blood; 2016 Feb; 127(5):582-95. PubMed ID: 26563132
[TBL] [Abstract][Full Text] [Related]
39. DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair.
Tomimatsu N; Mukherjee B; Harris JL; Boffo FL; Hardebeck MC; Potts PR; Khanna KK; Burma S
J Biol Chem; 2017 Jun; 292(26):10779-10790. PubMed ID: 28515316
[TBL] [Abstract][Full Text] [Related]
40. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.
Gatei M; Zhou BB; Hobson K; Scott S; Young D; Khanna KK
J Biol Chem; 2001 May; 276(20):17276-80. PubMed ID: 11278964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
